brain-tumor

Documents about brain-tumor

• Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme#804322ClinicalTrials.gov
• Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases#857081ClinicalTrials.gov
• Brain Tumor Analysis Empowered with Deep Learning: A Review, Taxonomy, and Future Challenges#335861OpenAlex
• Early Postoperative Inflammatory Indices Predict Long-Term Neuro-ICU Stay in Patients Requiring Prolonged Care After Supratentorial Brain Tumor Resection: Development and Validation of an Integrated Model.#480875NCBI PubMed Central
• Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)#980926ClinicalTrials.gov
• Space flight and central nervous system: Friends or enemies? Challenges and opportunities for neuroscience and neuro-oncology#1053682IRIS
• Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors#844270ClinicalTrials.gov
• Enhanced Recovery After Surgery (ERAS) Versus Standard Postoperative Care in Elective Craniotomy for Brain Tumor Excision: A Comprehensive Review of Protocol Differences, Clinical Outcomes, and Implementation Challenges.#636354NCBI PubMed Central
• 3T MRI Biomarkers of Glioma Treatment Response#825367ClinicalTrials.gov
• Understanding Communication in Healthcare to Achieve Trust (U-CHAT)#842658ClinicalTrials.gov
• Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma#851887ClinicalTrials.gov
• Effects of Combined Music Therapy and Occupational Therapy on Motor and Physiological Parameters in Children With Neurological Impairments: A Non-Randomized Controlled Trial#878436ClinicalTrials.gov
• Efficacy and Safety of PEMbrolizumab PD-L1-positive (>50% of Tumor Cells), Advanced NSCL Cancer(PEMBREIZH)#1045209ClinicalTrials.gov
• Vinorelbine in Treating Children With Recurrent or Refractory Cancers#864583ClinicalTrials.gov
• Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery#842782ClinicalTrials.gov
• Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery#906834ClinicalTrials.gov
• A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations#1044831ClinicalTrials.gov
• Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas#881937ClinicalTrials.gov
• A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma#857296ClinicalTrials.gov
• Prospective Multicenter Evaluation of [ 11 C]Methionine PET/MRI Sensitivity Compared with MRI for Localizing Small Pituitary Neuroendocrine Tumor or Pituitary Adenoma in Cushing Disease#796275HAL (France)
• Dendritic Cell Cancer Vaccine for High-grade Glioma#878133ClinicalTrials.gov
• Temozolomide in Treating Patients With Recurrent High-Grade Glioma#1009121ClinicalTrials.gov
• Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma#884057ClinicalTrials.gov
• Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas#911385ClinicalTrials.gov
• Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas#855084ClinicalTrials.gov
• Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme#879154ClinicalTrials.gov
• The Prediction of Intracranial Pressure and Clinical Outcome by Transcranial Doppler in Neurocritical Patients#882026ClinicalTrials.gov
• Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research#979840ClinicalTrials.gov
• Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma#831530ClinicalTrials.gov
• Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical Study#889382ClinicalTrials.gov
• A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG)#1033583ClinicalTrials.gov
• Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma#804031ClinicalTrials.gov
• Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme#850497ClinicalTrials.gov
• DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas#877959ClinicalTrials.gov
• Non-canonical Hh signalling through Smoothened controls cytotoxic T cell migration in the tumor microenvironment#296529Apollo
• Single Patient Compassionate Use / Expanded Access L-S-Gboxin (Lyophilized Form of S-Gboxin) for the Treatment of Diffuse Midline Glioma#885511ClinicalTrials.gov
• Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.#804380ClinicalTrials.gov
• EBTAG: explainable brain tumor segmentation with EfficientNetV2, attention mechanism, and Grad-CAM in clinical and public datasets#435103Springer Nature OA
• Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent Glioma#840645ClinicalTrials.gov
• Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors#894499ClinicalTrials.gov
• Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy#994228ClinicalTrials.gov
• Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma#1030000ClinicalTrials.gov
• Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma#810782ClinicalTrials.gov
• Interest of a Weekly Consultation by a Medical Electro Radiology Manipulator (MERM) in Addition to the Follow-up by the Radiotherapist to Improve the Collection of Radio-induced Toxicities in Patients Undergoing Proton Therapy#1044180ClinicalTrials.gov
• Comparison of the Analgesic Effects of Scalp Nerve Block and Intravenous Ibuprofen Applications Under the Guidance of Nociception Level Index (NoL) in Patients Undergoing Elective Supratentorial Craniotomy#846819ClinicalTrials.gov
• Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases#905162ClinicalTrials.gov
• A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas#992965ClinicalTrials.gov
• First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study)#333826HAL (France)
• Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme#846398ClinicalTrials.gov
• Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma#848256ClinicalTrials.gov